Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine 0.2% mucoadhesive gel for prevention of ventilator-associated pneumonia
IRCT20101211005363N14Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of chlorhexidine in ventilator-associated pneumonia (VAP), sponsored by Zanjan University of Medical Sciences. Started Apr 2019; status: completed.
02
Drugs
chlorhexidine
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on IRCT20101211005363N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101211005363N14.